These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7879706)

  • 1. Pharmacological management of chronic pain: a clinician's perspective.
    Cherry DA; Gourlay GK
    Agents Actions; 1994 Oct; 42(3-4):173-4. PubMed ID: 7879706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacologic management of pain in children.
    Yaster M; Deshpande JK; Maxwell LG
    Compr Ther; 1989 Oct; 15(10):14-26. PubMed ID: 2680242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid agonist-antagonist drugs in acute and chronic pain states.
    Hoskin PJ; Hanks GW
    Drugs; 1991 Mar; 41(3):326-44. PubMed ID: 1711441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
    Gourlay GK
    Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of tramadol.
    Grond S; Sablotzki A
    Clin Pharmacokinet; 2004; 43(13):879-923. PubMed ID: 15509185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease.
    Murphy EJ
    Anaesth Intensive Care; 2005 Jun; 33(3):311-22. PubMed ID: 15973913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Difference in tolerance to anti-hyperalgesic effect and its molecular mechanisms between chronic treatment with morphine, fentanyl and oxycodone in a chronic pain-like state].
    Satoshi I; Narita M; Ozeki A; Nakamura A; Hashimoto S; Narita M; Kuzumaki N; Uezono Y; Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Nov; 28(5-6):169-76. PubMed ID: 19108502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New strategies in opioid therapy for cancer pain.
    Cherny N
    J Oncol Manag; 2000; 9(1):8-15. PubMed ID: 10787576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes.
    Bolan EA; Tallarida RJ; Pasternak GW
    J Pharmacol Exp Ther; 2002 Nov; 303(2):557-62. PubMed ID: 12388636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sustained-release Opioids: Morphine, Oxycodone and Tapentadol].
    Takahashi Y; Iseki M
    Masui; 2015 Nov; 64(11):1133-40. PubMed ID: 26689063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic drugs in the management of pain.
    Halpern LM
    Arch Surg; 1977 Jul; 112(7):861-9. PubMed ID: 18128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesics and other drugs for relief of pain.
    Halpern LM
    Postgrad Med; 1973 May; 53(6):91-100. PubMed ID: 4701617
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the use of different analgesics in the course of anesthesia care based on pharmacoeconomics.
    Ping Y; Jing C; Qing J
    Pak J Pharm Sci; 2018 Sep; 31(5(Special)):2241-2247. PubMed ID: 30463819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
    Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
    Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
    Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain and pain treatments in European palliative care units. A cross sectional survey from the European Association for Palliative Care Research Network.
    Klepstad P; Kaasa S; Cherny N; Hanks G; de Conno F;
    Palliat Med; 2005 Sep; 19(6):477-84. PubMed ID: 16218160
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.